Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/94784/000095013509002376/b73475ape10vk.htm
SEC Filings
ALSE Annual Reports
ALSE Quarterly Reports
10-Q Quarterly Report August 2014
10-Q Quarterly Report August 2014
10-Q Quarterly Report May 2014
10-Q Quarterly Report May 2014
10-Q Quarterly Report November 2013
10-Q Quarterly Report November 2013
10-Q Quarterly Report August 2013
10-Q Quarterly Report August 2013
10-Q Quarterly Report May 2013
10-Q Quarterly Report May 2013
10-Q Quarterly Report August 2014
10-Q Quarterly Report August 2014
10-Q Quarterly Report May 2014
10-Q Quarterly Report May 2014
10-Q Quarterly Report November 2013
10-Q Quarterly Report November 2013
10-Q Quarterly Report August 2013
10-Q Quarterly Report August 2013
10-Q Quarterly Report May 2013
10-Q Quarterly Report May 2013
Last10K.com | 10-K Annual Report Tue Mar 31 2009
View differences made from one year to another to evaluate Alseres Pharmaceuticals Inc De's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Alseres Pharmaceuticals Inc De.
Assess how Alseres Pharmaceuticals Inc De's management team is paid from their Annual Proxy
Alseres Pharmaceuticals Inc De's Definitive Proxy Statement (Form DEF 14A) filed after their 2009 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Material Contracts, Statements, Certifications & more
Alseres Pharmaceuticals Inc De provided additional information to their SEC Filing as exhibits
Exhibit 10.33: Material Contract
Exhibit 10.37: Material Contract
Exhibit 10.38: Material Contract
Exhibit 10.44: Material Contract
Exhibit 10.45: Material Contract
Exhibit 10.46: Material Contract
Exhibit 10.47: Material Contract
Exhibit 21: Subsidaries Of The Registrant
Exhibit 23.1: Consents Of Experts And Counsel
Exhibit 23.2: Consents Of Experts And Counsel
Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Exhibit 32.2: Section 1350 Certification
Ticker: ALSE
CIK: 94784
Form Type: 10-K Annual Report
Accession Number: 0000950135-09-002376
Submitted to the SEC: Tue Mar 31 2009 3:18:48 PM EST
Accepted by the SEC: Tue Mar 31 2009
Period: Wednesday, December 31, 2008
Industry: Pharmaceutical Preparations
External Resources:
Stock Quote
Social Media
SEC.gov
Bookmark the Permalink: https://last10k.com/sec-filings/alse/0000950135-09-002376.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...